We investigated whether the combination of a HFD and eNOS‐derived NO deficiency affected lipid and fatty acid deposition in the intraperitoneal cavity (indicator of obesity) and in the liver (indicator of NAFLD) by comparing eNOS−/− mice with their WT counterparts (Figure 1a). Here, NOS3 is linked to metabolic dysfunction-associated steatotic liver disease.